Sangita Shah
Corporate Officer/Principal en PreEmptive Meds, Inc. .
Fortuna: 62 118 $ al 30/04/2024
Perfil
Sangita Shah currently works in finance and accounting at PreEmptive Meds, Inc. and currently holds a managerial position in the same field at the same company.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FORWARD INDUSTRIES INC.
1.10% | 22/12/2023 | 111 123 ( 1.10% ) | 62 118 $ | 30/04/2024 |
Cargos activos de Sangita Shah
| Empresas | Cargo | Inicio |
|---|---|---|
PreEmptive Meds, Inc.
 PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
PreEmptive Meds, Inc.
PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Sangita Shah
